---
title: "BioLargo Secures $10 Million Equity Purchase Facility With Clearthink"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/280529909.md"
description: "BioLargo has secured a $10 million equity purchase facility with Clearthink, allowing access to equity capital over 36 months once a resale registration is effective. Purchase notices are limited to $500,000 or 300% of recent trading value, with pricing based on the average of the two lowest daily closes over the last eight trading days. BioLargo issued 500,000 commitment shares to Clearthink and signed a registration rights agreement to facilitate the resale of shares by the investor."
datetime: "2026-03-25T21:13:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280529909.md)
  - [en](https://longbridge.com/en/news/280529909.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280529909.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/280529909.md) | [繁體中文](https://longbridge.com/zh-HK/news/280529909.md)


# BioLargo Secures $10 Million Equity Purchase Facility With Clearthink

BioLargo entered into a committed equity purchase facility of up to $10.0 million with Clearthink, providing discretionary access to equity capital over a 36-month period once a resale registration is effective. Purchase notices are capped by the lesser of $500,000 or 300% of recent trading value per notice, with pricing set to the average of the two lowest daily closes over the prior eight trading days and a 9.99% ownership cap. As consideration, BioLargo issued 500,000 commitment shares to Clearthink. In a related move, BioLargo signed a registration rights agreement to register the investor’s resale of shares, a condition to commencing the facility.

**Agreement 1: BioLargo Secures $10 Million Equity Purchase Facility With Clearthink**

-   **Agreement type**: Committed equity purchase agreement for up to $10.0 million of common stock
-   **Counterparty**: Clearthink Capital Partners
-   **Signed / Effective**: Mar 20 2026 / same
-   **Duration / Termination**: Up to 36 months
-   **Reason**: Provide flexible access to equity capital for working capital and general purposes

**Agreement 2: BioLargo Enters Registration Rights Agreement to Support Clearthink Resale**

-   **Agreement type**: Registration rights agreement for resale of common stock
-   **Counterparty**: Clearthink Capital Partners
-   **Signed / Effective**: Mar 20 2026 / same
-   **Reason**: Enable resale by investor to activate equity line

Original SEC Filing: BIOLARGO, INC. \[ BLGO \] - 8-K - Mar. 25, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [BioLargo, Inc. (BLGO.US)](https://longbridge.com/en/quote/BLGO.US.md)

## Related News & Research

- [BioLargo Issues Investor Presentation Under Regulation FD Disclosure](https://longbridge.com/en/news/277981400.md)
- [If You Invested $1000 In iShares Russell 1000 Growth Fund Stock 10 Years Ago, You Would Have This Much Today](https://longbridge.com/en/news/280189334.md)
- [Here's How Much $1000 Invested In Ubiquiti 10 Years Ago Would Be Worth Today](https://longbridge.com/en/news/280525208.md)
- [Here's How Much $1000 Invested In Delta Air Lines 15 Years Ago Would Be Worth Today](https://longbridge.com/en/news/280345078.md)
- [Here's How Much $1000 Invested In Axon Enterprise 5 Years Ago Would Be Worth Today](https://longbridge.com/en/news/280654015.md)